Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ACT Biotech describes activity of Aurora kinase inhibitor ACTB-1010

Dec. 7, 2010

Oncolytic prodrug BMS-817378 selected for clinical development

Dec. 7, 2010

Merck KGaA divulges novel inhibitors of protein kinases

Dec. 7, 2010

TAvi6, a bispecific antibody targeting VEGF-A/ANG-2 inhibits angiogenesis in vivo

Dec. 3, 2010

Ascenta Therapeutics and Ascentage Pharma form alliance for cancer programs

Dec. 3, 2010

GenSpera adds trial site to G-202 phase I clinical program

Dec. 3, 2010

Chugai Pharma presents in vivo data on new potential cancer therapeutics

Dec. 3, 2010

Agennix discloses interim data from first-in-human trial of RGB-286638 in hematologic tumors

Dec. 3, 2010

Oncolytics Biotech begins enrollment in phase II Reolysin study in ovarian cancer

Dec. 2, 2010

FDA to request further information for Cavatak IND for phase II melanoma trial

Dec. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Makary out at the FDA
BioWorld
U.S. President Donald Trump ended days of rumors and speculation when he confirmed May 12 that Marty Makary is resigning as FDA commissioner. Speaking with...